Publications

  1. Moynagh MR, Dowdy SC, Welch B, Glaser GE, Schmitz JJ, Jatoi A, Langstraat CL, Block MS, Kurup AN, Kumar A. Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program. Gynecol Oncol. 2021 Mar; 160 (3):835-843 Epub 2020 Dec 30
    View PubMed
  2. Narasimhulu DM, Thannickal A, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy. Gynecol Oncol. 2021 Mar; 160 (3):681-687 Epub 2020 Dec 31
    View PubMed
  3. Glaser G, Dinoi G, Multinu F, Yost K, Al Hilli M, Larish A, Kumar A, McGree M, Weaver AL, Cheville A, Dowdy S, Mariani A. Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer. Int J Gynecol Cancer. 2021 Jan; 31 (1):85-91 Epub 2020 Nov 26
    View PubMed
  4. Block MS, Dietz AB, Gustafson MP, Kalli KR, Erskine CL, Youssef B, Vijay GV, Allred JB, Pavelko KD, Strausbauch MA, Lin Y, Grudem ME, Jatoi A, Klampe CM, Wahner-Hendrickson AE, Weroha SJ, Glaser GE, Kumar A, Langstraat CL, Solseth ML, Deeds MC, Knutson KL, Cannon MJ. Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nat Commun. 2020 Oct 14; 11 (1):5173
    View PubMed
  5. Larish A, Kumar A, Weaver A, Mariani A. Impact of hysteroscopy on course of disease in high-risk endometrial carcinoma. Int J Gynecol Cancer. 2020 Oct; 30 (10):1513-1519 Epub 2020 Aug 26
    View PubMed
  6. Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, Langstraat CL, Block MS, Kumar A. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020 Sep; 158 (3):646-652 Epub 2020 June 06
    View PubMed
  7. Yang J, Delara R, Ghaith S, Newman H, Magrina J, Butler K, Kumar A, Dinh T, Chen L, Magtibay P. Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 2020 Sep; 158 (3):555-561 Epub 2020 July 03
    View PubMed
  8. Schafer MJ, Zhang X, Kumar A, Atkinson EJ, Zhu Y, Jachim S, Mazula DL, Brown AK, Berning M, Aversa Z, Kotajarvi B, Bruce CJ, Greason KL, Suri RM, Tracy RP, Cummings SR, White TA, LeBrasseur NK. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight. 2020 Jun 18; 5 (12) Epub 2020 June 18
    View PubMed
  9. Narasimhulu DM, Cope A, Riaz IB, Petersen I, Cilby W, Langstraat C, Glaser G, Kumar A, Cappuccio S, Murad MH, West C, Mariani A. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2020 Jun; 30 (6):797-805 Epub 2020 Mar 26
    View PubMed
  10. Narasimhulu DM, Kumar A, Weaver AL, Langstraat CL, Cliby WA. Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management. Gynecol Oncol. 2020 Jun; 157 (3):572-577 Epub 2020 Apr 01
    View PubMed
  11. Glaser GE, Kalogera E, Kumar A, Yi J, Destephano C, Ubl D, Glasgow A, Habermann E, Dowdy SC. Outcomes and patient perspectives following implementation of tiered opioid prescription guidelines in gynecologic surgery. Gynecol Oncol. 2020 May; 157 (2):476-481 Epub 2020 Feb 24
    View PubMed
  12. Kumar A, Cliby WA. Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery. Clin Obstet Gynecol. 2020 Mar; 63 (1):74-79
    View PubMed
  13. Stukan M, Bugalho A, Kumar A, Kowalewska J, Swietlik D, Buda N, Pietrzak-Stukan M, Dudziak M. Lung and Intercostal Upper Abdomen Ultrasonography for Staging Patients with Ovarian Cancer: A Method Description and Feasibility Study. Diagnostics (Basel). 2020 Feb 5; 10 (2) Epub 2020 Feb 05
    View PubMed
  14. Casarin J, Multinu F, Tortorella L, Cappuccio S, Weaver AL, Ghezzi F, Cilby W, Kumar A, Langstraat C, Glaser G, Mariani A. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes. Int J Gynecol Cancer. 2020 Jan; 30 (1):41-47 Epub 2019 Nov 27
    View PubMed
  15. Littell RD, Kumar A, Einstein MH, Karam A, Bevis K. Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide. Gynecol Oncol. 2019 Oct; 155 (1):161-169 Epub 2019 Aug 16
    View PubMed
  16. Narasimhulu DM, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2019 Oct; 155 (1):58-62 Epub 2019 Aug 08
    View PubMed
  17. Tortorella L, Casarin J, Multinu F, Cappuccio S, McGree ME, Weaver AL, Langstraat CL, Keeney GL, Kumar A, Melis GB, Angioni S, Scambia G, Mariani A, Glaser GE. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping. Gynecol Oncol. 2019 Oct; 155 (1):34-38 Epub 2019 Aug 08
    View PubMed
  18. Kilts TP, Glaser GE, Langstraat CL, Kumar A, Weaver AL, Mc Gree ME, Gostout BS, Podratz KC, Dowdy SC, Cliby WA, Mariani A, Bakkum-Gamez JN. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer. Gynecol Oncol. 2019 Oct; 155 (1):21-26 Epub 2019 Aug 10
    View PubMed
  19. Shafa A, Kumar A, Torres D, McKenzie TJ. Minimally Invasive Hysterectomy and Bariatric Surgery to Improve Endometrial Cancer Survivorship. Obstet Gynecol. 2019 Sep; 134 (3):570-572
    View PubMed
  20. Kumar A, Martin DP, Dhanorker SR, Brandt SR, Schroeder DR, Hanson AC, Cima RR, Dowdy SC. Improving the rate of surgical normothermia in gynecologic surgery. Gynecol Oncol. 2019 Sep; 154 (3):590-594 Epub 2019 July 05
    View PubMed
  21. Torres D, Shafa A, Klennert S, Hokenstad A, Bird M, Weinhold M, Mundi MS, Langstraat C, Kumar A. Using quality improvement to increase the awareness of obesity among endometrial cancer patients. Int J Gynecol Cancer. 2019 Jul; 29 (6):1010-1015 Epub 2019 June 14
    View PubMed
  22. Kumar A, Sheedy S, Kim B, Suidan R, Sarasohn DM, Nikolovski I, Lakhman Y, McGree ME, Weaver AL, Chi D, Cliby WA. Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease. Gynecol Oncol. 2019 Jul; 154 (1):72-76 Epub 2019 Apr 16
    View PubMed
  23. Kumar A, Wallace SA, Cliby WA, Glaser GE, Mariani A, Leitao MM, Frumovitz M, Langstraat CL. Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol. 2019 May - Jun; 26 (4):727-732 Epub 2018 Aug 20
    View PubMed
  24. Mert I, Kumar A, Torres D, Huang Y, McGree ME, Weaver AL, Cliby WA. Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease? Gynecol Oncol. 2019 May; 153 (2):238-241 Epub 2019 Mar 02
    View PubMed
  25. Yao T, DeJong SR, McGree ME, Weaver AL, Cliby WA, Kumar A. Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery. Gynecol Oncol. 2019 Apr; 153 (1):68-73 Epub 2019 Jan 03
    View PubMed
  26. Kumar A, Nesbitt KM, Bakkum-Gamez JN. Quality improvement in gynecologic oncology: Current successes and future promise. Gynecol Oncol. 2019 Mar; 152 (3):486-491
    View PubMed
  27. Kalogera E, Glaser GE, Kumar A, Dowdy SC, Langstraat CL. Enhanced Recovery after Minimally Invasive Gynecologic Procedures with Bowel Surgery: A Systematic Review. J Minim Invasive Gynecol. 2019 Feb; 26 (2):288-298 Epub 2018 Oct 24
    View PubMed
  28. Torres D, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Wang C, Langstraat CL, Cliby WA. Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2019 Feb; 152 (2):223-227 Epub 2018 Nov 28
    View PubMed
  29. Wagner BE, Langstraat CL, McGree ME, Weaver AL, Sarangi S, Mokri B, Dowdy SC, Cliby WA, Kumar A, Bakkum-Gamez JN. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer. Gynecol Oncol. 2019 Feb; 152 (2):286-292 Epub 2018 Nov 22
    View PubMed
  30. Casarin J, Multinu F, Pasupathy K, Weaver A, McGree M, Tortorella L, Torres D, Kumar A, Langstraat C, Huang Y, Ghezzi F, Mariani A, Glaser G. Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging. Ann Surg Oncol. 2018 Nov; 25 (12):3692-3698 Epub 2018 Aug 16
    View PubMed
  31. Hinchcliff E, Green I, Destephano C, Cox M, Smink D, Kumar A, Hokenstad E, Bengtson J, Cohen SL. Visuospatial Aptitude Testing Differentially Predicts Simulated Surgical Skill. J Minim Invasive Gynecol. 2018 Sep - Oct; 25 (6):1044-1050 Epub 2018 Feb 05
    View PubMed
  32. Torres D, Wang C, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Konecny GE, Goode EL, Cliby WA. Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability. Gynecol Oncol. 2018 Aug; 150 (2):227-232 Epub 2018 June 18
    View PubMed
  33. Swanson CL, Kumar A, Maharaj JM, Kemppainen JL, Thomas BC, Weinhold MR, Slaby KM, Mara KC, Wick MJ, Bakkum-Gamez JN. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis. Gynecol Oncol. 2018 Apr; 149 (1):121-126 Epub 2018 Feb 03
    View PubMed
  34. Mert I, Kumar A, Sheedy SP, Weaver AL, McGree ME, Kim B, Cliby WA. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival. Gynecol Oncol. 2018 Jan; 148 (1):68-73 Epub 2017 Nov 10
    View PubMed
  35. Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN. Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses. Gynecol Oncol. 2017 Dec; 147 (3):514-520 Epub 2017 Sept 22
    View PubMed
  36. Torres D, Kumar A, Wallace SK, Bakkum-Gamez JN, Konecny GE, Weaver AL, McGree ME, Goode EL, Cliby WA, Wang C. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer. Gynecol Oncol. 2017 Dec; 147 (3):503-508 Epub 2017 Sept 28
    View PubMed
  37. Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer. Gynecol Oncol. 2017 Oct; 147 (1):104-109 Epub 2017 July 19
    View PubMed
  38. Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A. Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer. Anticancer Res. 2017 Jul; 37 (7):3673-3677
    View PubMed
  39. Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol. 2017 Apr; 145 (1):21-26 Epub 2017 Jan 31
    View PubMed
  40. Larish A, Kumar A, Kerr S, Langstraat C. Primary Gastric Choriocarcinoma Presenting as a Pregnancy of Unknown Location. Obstet Gynecol. 2017 Feb; 129 (2):281-284
    View PubMed
  41. Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016 Aug; 142 (2):311-6 Epub 2016 June 02
    View PubMed
  42. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
    View PubMed
  43. Janco JM, Kumar A, Weaver AL, McGree ME, Cliby WA. Performance of AGO score for secondary cytoreduction in a high-volume U.S. center. Gynecol Oncol. 2016 Apr; 141: (1)140-7.
    View PubMed
  44. Smits A, Lopes A, Das N, Kumar A, Cliby W, Smits E, Bekkers R, Massuger L, Galaal K. Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG. 2015 Sep 02.
    View PubMed
  45. Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2016 Jan; 140 (1):15-21 Epub 2015 Nov 02
    View PubMed
  46. Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015 May; 23 (5):1303-9 Epub 2014 Oct 23
    View PubMed
  47. Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014 Oct; 135 (1):19-24 Epub 2014 Aug 07
    View PubMed
  48. Weroha SJ, Becker MA, Enderica-Gonzalez S, Harrington SC, Oberg AL, Maurer MJ, Perkins SE, AlHilli M, Butler KA, McKinstry S, Fink S, Jenkins RB, Hou X, Kalli KR, Goodman KM, Sarkaria JN, Karlan BY, Kumar A, Kaufmann SH, Hartmann LC, Haluska P. Tumorgrafts as in vivo surrogates for women with ovarian cancer. Clin Cancer Res. 2014 Mar 1; 20 (5):1288-97 Epub 2014 Jan 07
    View PubMed